Search results

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.

Bushfires in proximity to ANSTO during the 2018 bushfires.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

Do you love science? Here is a competition for you that combines chemistry and creativity! Discover the world of elements and create a poster for your favourite element in this new competition for school aged students.

See details of previously published customer updates from our Health products team. 

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

Planning is now underway for a second repatriation project which is scheduled to take place in 2022. Find out more information.

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.